Register entry
OPELLA HEALTHCARE INTERNATIONAL SAS
- Registered sites
- 1
- Drug products
- 17
- Live patents
- 0
- Countries
- 1
- Base
- France
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackagingRelabellingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| OPELLA HEALTHCARE INTERNATIONAL SAS | CompiegneFrance | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3003492806 |
Catalogue
Marketed products
17Showing 17 of 17.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | FEXOFENADINE HYDROCHLORIDE | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | FEXOFENADINE HYDROCHLORIDE | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | Fexofenadine Hydrochloride | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | LEVOCETIRIZINE DIHYDROCHLORIDE | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Tadalafil | TABLET, COATED | DRUG FOR FURTHER PROCESSING |
| - | bisacodyl | TABLET, COATED | DRUG FOR FURTHER PROCESSING |
| - | bisacodyl | TABLET, COATED | DRUG FOR FURTHER PROCESSING |
| - | fexofenadine hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | glyburide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | glyburide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | glyburide | TABLET | DRUG FOR FURTHER PROCESSING |
| - | leflunomide | TABLET, FILM COATED | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | leflunomide | TABLET, FILM COATED | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | teriflunomide | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | teriflunomide | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | teriflunomide | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | teriflunomide | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.